NEW YORK (GenomeWeb News) — WaferGen Biosystems said today that it has acquired the next-generation sequencing library preparation business of IntegenX.

Under the agreement, WaferGen Inc., a subsidiary of WaferGen Biosystems, has acquired all of IntegenX's assets surrounding instruments and reagents related to NGS library preparation, including the Apollo 324 instrument and PrepX reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.